Heart Failure: Pharmacologic Management - Couverture rigide

Couverture rigide

ISBN 10 : 1405103612 ISBN 13 : 9781405103619

Editeur : Wiley-Blackwell, 2006

Synopsis

Book by None

A propos du livre

Présentation de l'éditeur

Now there is an up–to–date guide for optimizing pharmacologictherapy in treating patients with heart failure. Reflecting currentpractice at leading medical centers, Heart Failure:Pharmacologic Management provides both the biologic andpathologic underpinnings of each pharmacologic agent in currentuse. It also supplies detailed discussions of the clinicalinvestigations that support current understanding of the risks andbenefits associated with the use of these drugs. Thoroughreferences make the book useful to the novice as well as theexperienced clinician. Initial chapters focus on agents that are consideredstandard care: diuretics ACE inhibitors angiotensin receptor antagonists aldosterone antagonists beta–blockers The discussion moves to agents currently underinvestigation: Vasopressin antagonists erythropoietin Next, the authors consider some controversial drugs: inotropic agents antiarrhythmic drugs anticoagulants An insightful examination of pharmacogeneticsconsiders: how studies of the genetic profile of patients helps determinewhich patient populations are most likely to respond to a givenclass of drugs the potential use of pharmacogenetics to tailor a pharmacologicregimen for maximum benefit and minimum risk Multidrug pharmacy for heart failure therapy An extremely helpful concluding chapter provides a roadmap ofdrugs with which to approach the patient with heart failure, alongwith an overview of the skills you need to use it most effectively.This straightforward, step–by–step algorithm will save youcountless hours of research and help you make your prescribingdecisions with confidence.

Quatrième de couverture

Heart failure is a devastating disease of epidemic proportions.Physicians are faced with an increasingly large choice of treatmentoptions and questions including: how different genetic, racial andgender backgrounds can influence a patient s response; how tomonitor treatment once it has begun; and what side–effects can beexpected from these agents.

Heart Failure: Pharmacologic Management is the essentialguide for physicians working with these issues to optimise theiruse of pharmacologic therapy for patients with heart failure.

This extensively referenced text provides both the biologic andpathologic underpinning for the use of eachpharmacologic agentcurrently recommended, including the clinical investigations thathave led to our understanding of the risks and benefits associatedwith the use of these drugs. In addition, this book reviews severalareas, including vasopressin antagonists, that are under activeinvestigation, but which are expected to prove fruitful in thetherapy of patients with heart failure.

Heart Failure: Pharmacologic Management is written byindividuals with extensive expertise within the field and is theonly text to focus on pharmacologic therapy. It will assist thepractitioner in easily making sense of the extensive number oftreatment agents available and should be considered a vitalcontribution to your bookshelf.

Détails de l'édition

• Éditeur: Wiley-Blackwell
• Date d'édition: 2006
• ISBN 10: 1405103612
• ISBN 13: 9781405103619
• Reliure: Relié
• Langue: anglais
• Nombre de pages: 304
• Éditeur: Feldman Arthur M.